Dolman Law Group Representing Clients Who Experienced Hearing Loss After Receiving Popular Ear Injections
Nov 17, 2022
CLEARWATER, Fla. - November 17, 2022 - (Newswire.com)
A medication designed to treat symptoms of thyroid eye disease (TED) has been linked to cases of hearing-related issues in patients, according to Dolman Law Group. The personal injury and mass torts law firm is actively seeking to speak with individuals who believe they have experienced these side effects after taking this defective medication immediately.
The medication in question is an injectable prescription that has been manufactured by a major biopharmaceutical company. A study published in the Journal of Endocrine Society found that over half of patients who used said medication reported complications such as hearing loss, muffled hearing, tinnitus, clogged ears, and even autophony (the perception of one's voice being louder than it truly is).
While unconfirmed, Dolman Law Group believes the organization knew about the risks of its medication prior to the product's release.
"This is an incredibly unfortunate circumstance for patients who were seeking to resolve their existing eye conditions," said Matthew Dolman, a managing partner at Dolman Law Group.
"Out of the 26 individuals who participated in the study that brought these issues to light, 65% reported experiencing hearing-related issues. This was after 77% of the same test group stated that they had never had any prior auditory impairments whatsoever."
In order to seek compensation for damages inflicted by the medication's side effects, a plaintiff must first satisfy several criteria. Plaintiffs must have suffered significant damages that were directly caused by the injections — a lawsuit cannot be filed simply because a patient took the medication. Patients must also have suffered from either one of the aforementioned negative effects or from eustachian tube dysfunction, inner ear injury or hyperacusis.
Although it is too early to determine an exact figure, projections from the Lawsuit Information Center place the potential settlement value at anywhere between $140,000 to $250,000 per patient.
"Patients who have suffered because of this extreme oversight have every right to seek compensation. With our award-winning legal representation and extensive legal resources, our firm is prepared to provide new clients with the undivided attention that they deserve as they look to win their respective cases," said Dolman.
To speak to a representative from the Dolman Law Group regarding a potential hearing loss lawsuit, please visit https://www.dolmanlaw.com/contact-us.
About Dolman Law Group
The Dolman Law Group is a nationally recognized personal injury and mass tort law firm. As of date, our lawyers have obtained over $250 million in financial compensation for serious injury victims. Dolman Law Group attorneys have over 130+ years of combined experience. Matthew Dolman is a lifetime member of the Million Dollar Advocates Forum and the Multi-Million Dollar Advocates Forum for resolving individual cases in excess of $1 million and $2 million, respectively. Stanley Gipe is a Board Certified civil trial lawyer as designated by the Florida Bar.
Contact Information:
Matthew Dolman
Owner
[email protected]
833-552-7274
Related Images
Press Release Service by Newswire.com
Original Source: Dolman Law Group Representing Clients Who Experienced Hearing Loss After Receiving Popular Ear Injections
More News
Use of GLP-1s Like Ozempic Is Forcing Food Companies to Adapt
People on medications for weight loss are buying less food, shrinking their portion sizes and purchasing smaller clothes. Businesses are trying to adjust.
Flight chaos caused by 'millisecond' software defect, report says
The failure led to more than 2,000 flights being cancelled and hundreds of thousands of passengers affected.
Kremlin Moves to Seize Control of Nestlé’s Russia Operations
The Swiss maker of KitKats and Nescafé said it was assessing the situation after the Kremlin issued a presidential decree.
Amodei, Anthropic’s Leader, Exposed A.I.’s Dangers. It’s Time to Act.
Times columnist Kevin Roose sees reasons for optimism — and worry — as the world wakes up to what Silicon Valley has been talking about for years.
Dragon Deborah opens with a terrible negotiation tactic
Deborah Meaden makes a bold opening move in response to a pitch.
'Insufficient funds' to pay Brewdog creditors after takeover deal
Administrators say about £489,000 was owed for staff wages and holiday pay and £2.4m was owed to HMRC for unpaid VAT.
China Stockpiled Oil, and Now It Could Dominate the Energy Landscape
The war with Iran revealed just how much influence the world’s biggest oil importer has over prices and other countries’ supplies of jet fuel, gasoline and diesel.
British Steel plan lacks credibility, MPs say
A committee report says the government has not set out how British Steel will become profitable.
Native American Tribe Teams Up With Kalshi on New Prediction Market
The Tunica-Biloxi of Louisiana plan to release a platform that uses infrastructure by Kalshi, the industry leader. Other tribes have taken aim at the company.
Economy minister accuses SoS of 'mischief making' in social media exchange
Dr Caoimhe Archibald posted on X about a new one-off electricity bill reduction, which Sir Chris Bryant reposted saying the UK government funded it.
We bought our £242,000 home without a deposit - here's how
The share of UK mortgages with smaller deposits is the highest it's been since 2008. The BBC spoke to borrowers about how they manage the risks.
Former shoplifter ran 'steal-to-order' Whatsapp group
Keeley Knowles ran a Whatsapp group with about 200 people asking her to steal specific designer items.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.